---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-26-000019"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:17:07.315794+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences amends $150M A/R facility, extends termination to April 2029

## Summary
- Scheduled termination date of $150M accounts receivable securitization facility extended to April 10, 2029.
- Amends representations, covenants, and concentration limits under the Receivables Financing Agreement.
- Also amends Purchase and Sale Agreement with similar covenant changes; PNC Bank remains administrative agent.
- The Bank of Nova Scotia remains a committed lender and group agent under the facility.

## SEC filing metadata
- accession: 0000917520-26-000019
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752026000019/0000917520-26-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752026000019/iart-20260410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-26-000019
- JSON: https://secwatch.observer/filing/0000917520-26-000019.json
- Plain text: https://secwatch.observer/filing/0000917520-26-000019.txt

## Source-grounded claims
- claim_id: 6209f18645f724c9c466933673604aadb00a888b
  claim: INTEGRA LIFESCIENCES HOLDINGS CORP entered into April 2026 Amendments with PNC Bank, National Association valued at amendment to $150 million accounts receivable securitization facility (effective 2026-04-10).
  evidence_excerpt: On April 10, 2026, (i) the Borrower and ILS Sales entered into Amendment No. 8 to Receivables Financing Agreement (the “RFA Amendment”), by and among the Borrower, ILS Sales, as Servicer, PNC, as Administrative Agent and Committed Lender, The Bank of Nova Scotia, as Committed Lender and Group Agent, PNC Capital Markets LLC, as Structuring Agent, and certain lenders and group agents that are parties thereto from time to time and (ii) the Borrower and ILS Sales entered into Amendment No. 1 to Purchase and Sale Agreement(the “PSA Amendment,” and together with the RFA Amendment, the “April 2026 Amendments”), by and between the Borrower, as Buyer and ILS Sales, as Servicer, and acknowledged and agreed by PNC, as Administrative Agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752026000019/0000917520-26-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.